Press Release: StrideBio : StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--StrideBio announces a multi-technology license and master sponsored research agreement with Duke University which will support R&D for gene therapies.
Read full article »
StrideBio is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders.
Read more